MedTrace Logo

A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections

NCT01049438 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2010-01-14

No results posted yet for this study

Summary

This clinical trial tests the hypothesis that body decolonization of patients with recurrent community-associated (CA) MRSA infections will significantly reduce the likelihood of recurrent CA-MRSA infection.

Conditions

  • Methicillin Resistant Staphylococcus Aureus Skin Infections

Interventions

DRUG

nasal mupirocin

twice daily for 10 days

DRUG

topical 3% hexachlorophene body wash

daily for 10 days

DRUG

oral anti-MRSA antibiotic

The choice of oral antibiotic was based on investigators choice and antibiotic susceptibility of prior MRSA isolates in a given patient

Sponsors & Collaborators

  • Natividad Medical Center

    lead OTHER

Principal Investigators

  • Allen Radner, M.D. · Navidad Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2009-09-30
Completion
2009-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01049438 on ClinicalTrials.gov